The Influence of Cancer Stem-cells on Risk of Relapse in Patients

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06003075` - Induction Chemo-Nivo in Unresectable Stage III NSCLC	Phase 2
Enrolling by invitation	`NCT06293833` - Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan	N/A
Recruiting	`NCT03705806` - Palliative Thoracic ImmunoRT
Not yet recruiting	`NCT06060964` - Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management	Early Phase 1
Completed	`NCT03689634` - Move For Surgery - A Novel Preconditioning Program	Phase 3
Recruiting	`NCT05537922` - I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
Completed	`NCT03902834` - Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery	N/A
Active, not recruiting	`NCT03322072` - Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating	N/A
Completed	`NCT02995889` - FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer	N/A
Recruiting	`NCT04237805` - A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients	Phase 1/Phase 2
Terminated	`NCT05061940` - This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Recruiting	`NCT05860296` - Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers	Phase 1/Phase 2
Enrolling by invitation	`NCT05863013` - Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer	N/A
Suspended	`NCT02991651` - Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC	Phase 1
Enrolling by invitation	`NCT04678440` - [18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients	Early Phase 1
Recruiting	`NCT04222335` - Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients	N/A
Recruiting	`NCT04415320` - X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases	Phase 2
Recruiting	`NCT02786589` - Plasmodium Immunotherapy for Lung Cancer	Phase 1/Phase 2
Recruiting	`NCT05085028` - A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)	Phase 3
Recruiting	`NCT05956782` - Breathe Easier II: A Dyad-based Multiple Behavior Intervention	N/A

NCT number	NCT04634630
Study type	Observational
Source	Azienda Ospedaliero-Universitaria di Modena
Contact
Status	Completed
Phase
Start date	October 17, 2017
Completion date	October 17, 2020

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms